
Misconduct and the future of neurodegenerative disease research
The Top Line
Challenges and Future Directions in Parkinson's Drug Targeting
This chapter explores the challenges of targeting alpha-synuclein in Parkinson's disease and evaluates the limitations of current immunotherapy strategies. It highlights the need for innovative approaches in drug development to effectively address this complex target in neurodegenerative treatments.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.